Naltrexone/bupropion prolonged release

Publisher： John Wiley & Sons Inc

E-ISSN： 2047-2900|32|3|114-115

ISSN： 2047-2897

Source： PRACTICAL DIABETES (INCORPORATING CARDIABETES), Vol.32, Iss.3, 2015-04, pp. : 114-115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

By  

CLINICAL OBESITY, Vol. 5, Iss. 5, 2015-10 ,pp. : 237-244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interest in Extended Release Naltrexone among Opioid Users

By  

European Addiction Research, Vol. 22, Iss. 6, 2016-07 ,pp. : 301-305

Karger

Access to resources Recommend Favorite

Naltrexone Implants Compared to Methadone: Outcomes Six Months after Prison Release

By  

European Addiction Research, Vol. 16, Iss. 3, 2010-04 ,pp. : 139-145

Karger

Access to resources Recommend Favorite

Prolonged‐release budesonide for mild‐to‐moderate ulcerative colitis

By  

PRESCRIBER, Vol. 26, Iss. 22, 2015-11 ,pp. : 27-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extended Release Naltrexone for Alcohol Use Disorders: Quasi‐Experimental Effects on Mortality and Subsequent Detoxification Episodes

By  

ALCOHOLISM (ELECTRONIC), Vol. 39, Iss. 1, 2015-01 ,pp. : 79-83

John Wiley & Sons Inc

Access to resources Recommend Favorite